T cell responses were analyzed through immunohistochemistry (IHC) staining for CD3, CD4, CD7, CD8, CD25, TIA‐1, HLA‐DR, and Ki67 (proliferative marker) on tumor biopsy samples. Here, CD8A is linked to neoplasm.